Background Since the routine method of anti-Xa factor assay cannot be used as a bedside test, this study was designed to investigate the correlation between activated clotting time (ACT) detected by a Sonoclot Analyzer and the anti-Xa factor assay.
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Peng PingAn,Qin Mingzhao.COMPARISON OF ANTI-XA FACTOR ASSAY AND ACT FOR MONITORING THE ANTICOAGULATION EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS IN ELDERLY PATIENTS[J].HEART.2011,97:A188-A188.doi:10.1136/heartjnl-2011-300867.551.
APA:
Peng PingAn&Qin Mingzhao.(2011).COMPARISON OF ANTI-XA FACTOR ASSAY AND ACT FOR MONITORING THE ANTICOAGULATION EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS IN ELDERLY PATIENTS.HEART,97,
MLA:
Peng PingAn,et al."COMPARISON OF ANTI-XA FACTOR ASSAY AND ACT FOR MONITORING THE ANTICOAGULATION EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS IN ELDERLY PATIENTS".HEART 97.(2011):A188-A188